• Products

Introduction

  • GNE-2861, CAS 1394121-05-1
    (World's Largest Pharmaceutical Supplier)

    CAS Number: 1394121-05-1
    Stock: 997g
    Assay: 98.64%

Details

CAS Number:1394121-05-1
Catalog Number:
Chemcial Name:
MW(Molecular Weight):
MF(Molecular Formula):
SMILES:GNE-2861, CAS 1394121-05-1GNE-2861, CAS 1394121-05-1,?Stock?897g,?Assay?98.64%,?White powder,?Water?0.24%,?Single Impurity?0.32%.GNE-2861GNE-2861 is a potent and exquisitely kinase-selective Group II PAK inhibitor (PAK4 Ki = 3 nM). GNE-2861 sensitized tamoxifen resistant MCF-7/LCC2 breast cancer cells to tamoxifen. PAK4 is overexpressed and/or genetically amplified in lung, colon, prostate, pancreas, and breast cancer cell lines and tumor tissues.Product Details:Name: GNE-2861CAS#: 1394121-05-1Chemical Formula: C22H26N6O2Exact Mass: 406.2117Molecular Weight: 406.49Elemental Analysis: C, 65.01; H, 6.45; N, 20.68; O, 7.87Specification:Synonym: GNE-2861; GNE 2861; GNE2861.IUPAC/Chemical Name: 1-(2-(1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-1,3-benzodiazol-6-yl)ethynyl)cyclohexan-1-olIChi Key: RZXMIHOUHYSGJO-UHFFFAOYSA-NInChi Code: InChI=1S/C22H26N6O2/c1-30-14-13-25-21-26-17-6-5-16(7-11-22(29)9-3-2-4-10-22)15-18(17)28(21)19-8-12-24-20(23)27-19/h5-6,8,12,15,29H,2-4,9-10,13-14H2,1H3,(H,25,26)(H2,23,24,27)SMILES Code: OC1(C#CC2=CC=C3N=C(NCCOC)N(C4=NC(N)=NC=C4)C3=C2)CCCCC1Appearance: White powderPurity: >98% (or refer to the Certificate of Analysis)Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).Solubility: Soluble in DMSOShelf Life: >2 years if stored properlyDrug Formulation: This drug may be formulated in DMSOStock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).HS Tariff Code: 2934.99.9001Certification:

Your privacy is very important for us. When you visit our website, please agree to use all cookies. For more information about how we use cookies, please visit our Privacy Policy.